SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, the company offers microarray instruments for antibody testing workflow. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.

Dr. Eric  Brouwer Ph.D.

Chief Scientific Officer & Director

Mr. Russell  Peloquin

Vice President of Global Commercial Operations

Dr. Peter  Lea Ph.D.

Founder

Mr. Tim  McGough

Chief Commercial Officer

Mr. Morlan  Reddock C.F.A., CPA, CGA, M.B.A.

Chief Financial Officer & Vice President of Admin.

Mr. Andrew  Morris

Chief Executive Officer & Director

Advisor to the Board & Chief Executive Officer

Chief Scientific Officer & Advisor to the Board

Nome da empresa	Capitalização de mercado
Thyrocare Technologies Limited	0M
HTG Molecular Diagnostics, Inc.	0M
Global Cord Blood Corporation	0M
ANGLE plc	0M
Diaceutics PLC	0M
Myriad Genetics, Inc.	0M
Centogene N.V.	0M
DermTech, Inc.	0M
HTG Molecular Diagnostics, Inc.	0M

SQI Diagnostics Inc.

SQI Diagnostics Inc. Lista de concorrentes

Principais concorrentes